Clinical Trials Browser

Phase 3 × avelumab × Gastrointestinal × Clear all

NCT03827044 2022-10-07

POLEM

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Microsatellite Instability

NCT02625623 2020-11-24

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Phase 3 Completed

371 enrolled 18 charts

Gastrointestinal

Recurrence, Stomach Neoplasms